Ryuichi Saura
Overview
Explore the profile of Ryuichi Saura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
446
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Urakami H, Nikaido Y, Okuda Y, Kikuchi Y, Saura R, Okada Y
J Mov Disord
. 2024 Dec;
PMID: 39726196
Objective: Camptocormia has been considered to contribute to vertical gait instability and, at times, may also lead to forward instability in experimental settings in Parkinson's disease (PD). However, these aspects,...
2.
Unoki T, Hayashida K, Kawai Y, Taito S, Ando M, Iida Y, et al.
J Intensive Care
. 2023 Nov;
11(1):47.
PMID: 37932849
Providing standardized, high-quality rehabilitation for critically ill patients is a crucial issue. In 2017, the Japanese Society of Intensive Care Medicine (JSICM) promulgated the "Evidence-Based Expert Consensus for Early Rehabilitation...
3.
Nikaido Y, Urakami H, Okada Y, Kajimoto Y, Ishida N, Kawami Y, et al.
Clin Biomech (Bristol)
. 2022 Sep;
99:105757.
PMID: 36113194
Background: This study aimed to investigate whether dynamic gait stability differs between idiopathic normal-pressure hydrocephalus with high- and low-fall-risk. Methods: Participants comprised 40 idiopathic normal-pressure hydrocephalus patients and 23 healthy-controls....
4.
Nikaido Y, Urakami H, Okada Y, Akisue T, Kawami Y, Ishida N, et al.
J Neurol
. 2022 Sep;
270(1):357-368.
PMID: 36071284
Background: Gait-balance disturbances are core symptoms of idiopathic normal pressure hydrocephalus (iNPH). However, the rehabilitation effects of cerebrospinal fluid (CSF) shunting along with other treatment or no further treatment (natural...
5.
Kajimoto Y, Kameda M, Kambara A, Kuroda K, Tsuji S, Nikaido Y, et al.
Front Neurol
. 2022 Apr;
13:866352.
PMID: 35481276
Objectives: Because the progression of idiopathic normal pressure hydrocephalus (iNPH) is partially irreversible, we hypothesized that early intervention would markedly improve its prognosis. To test this hypothesis, we retrospectively investigated...
6.
Nikaido Y, Okada Y, Urakami H, Ishida N, Akisue T, Kawami Y, et al.
Acta Neurol Scand
. 2021 Oct;
145(2):215-222.
PMID: 34633069
Objectives: To clarify a characteristic of dynamic stability during gait in idiopathic normal pressure hydrocephalus (iNPH) and Parkinson's disease (PD), and to explore the association between dynamic stability and disease...
7.
Urakami H, Nikaido Y, Kuroda K, Ohno H, Saura R, Okada Y
Neurosci Res
. 2021 Jul;
173:80-89.
PMID: 34217731
Freezing of gait (FOG) appears to be associated with increased risk of forward falls in patients with Parkinson's disease (PD). This study aimed to experimentally validate forward gait instability in...
8.
Nikaido Y, Urakami H, Akisue T, Okada Y, Kawami Y, Ishida N, et al.
Acta Neurol Scand
. 2021 Mar;
144(1):21-28.
PMID: 33754339
Objectives: We evaluated the perceived and actual changes in gait and balance function immediately after cerebrospinal fluid (CSF) shunting in patients with idiopathic normal pressure hydrocephalus (iNPH), including those with...
9.
Kambara A, Kajimoto Y, Yagi R, Ikeda N, Furuse M, Nonoguchi N, et al.
Front Aging Neurosci
. 2021 Feb;
12:617150.
PMID: 33551791
The long-term prognosis of cognitive function in patients with idiopathic normal pressure hydrocephalus (iNPH) remains unclear. This study aimed to determine the long-term prognosis of cognitive function in patients with...
10.
Saito T, Makiura D, Inoue J, Doi H, Yakushijin K, Okamura A, et al.
Phys Ther Res
. 2021 Jan;
23(2):166-171.
PMID: 33489655
Objective: Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse event experienced by cancer patients. In general, CIPN is evaluated subjectively based on patient self-assessment or clinician-reported scales; evidence supporting the...